A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain
Overview
A trial, investigating the influence of injection speed and volume on the perception of subcutaneous injection pain.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Basic Science
- Masking: Double (Participant, Investigator)
- Study Primary Completion Date: September 2014
Interventions
- Other: 0.9% NaCl (sodium chloride)
Arms, Groups and Cohorts
- Experimental: Anti-diabetes medication
- Insulin
Clinical Trial Outcome Measures
Primary Measures
- injection pain
- Time Frame: within 24 hours after injection
Secondary Measures
- variability of injection pain
- Time Frame: within the first 24 hours after injection
Participating in This Clinical Trial
Inclusion Criteria
- Subject has signed the informed consent form prior to screening – Age 18-74 years at screening (both included) Exclusion Criteria:
- Known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit – Previous participation in this trial. Participation is defined as having received at least one injection
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 74 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Thomas Forst, Prof, MD, Principal Investigator, Profil Mainz GmbH & Co KG
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.